AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Publishing Language: Chinese | Open Access

Research progress on the relationship between vitamin K and atherosclerosis

Zijing Wang1, Xinyu Zhang1, Hongmei Yao2 ( )
The First Clinical Medical College, Shanxi Medical University, Taiyuan 030001
Cardiology Department, First Hospital of Shanxi Medical University, Taiyuan 030001, China
Show Author Information

Abstract

Atherosclerosis (AS), as the core pathological basis of cardiovascular disease (CVD), involves a multifactorial pathogenesis that includes lipid deposition, inflammatory response, endothelial injury, coagulation dysfunction, and vascular calcification (VC). The global burden of CVD continues to rise, with increasing prevalence and mortality rates, making prevention and personalized treatment key research focuses in public health. Vitamin K, a fat-soluble vitamin, primarily exists in two natural forms: phylloquinone (vitamin K1) and menaquinone (vitamin K2). Traditional understanding has concentrated on its role in coagulation regulation, but recent studies have confirmed its involvement in AS development through various pathways, such as modulating the activity of vitamin K-dependent proteins, exerting anti-inflammatory and antioxidant effects, regulating lipid metabolism, and intervening in the phenotypic transformation of vascular smooth muscle cells. This review explores the relationship between vitamin K and atherosclerosis. It summarizes vitamin K classification and its molecular mechanisms regulating atherosclerosis, discusses clinical correlations of vitamin K with the disease, as well as vitamin K effects on postmenopausal women, patients with chronic kidney disease and diabetes, and impacts of vitamin K antagonists. Future research prospects are proposed to provide a comprehensive insight into their correlation.

CLC number: R543.3 Document code: A Article ID: 1007-4368(2026)11-1721-15

References

【1】
【1】
 
 
Journal of Nanjing Medical University (Natural Sciences)
Pages 1721-1735

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wang Z, Zhang X, Yao H. Research progress on the relationship between vitamin K and atherosclerosis. Journal of Nanjing Medical University (Natural Sciences), 2026, 46(11): 1721-1735. https://doi.org/10.7655/NYDXBNSN260080

1

Views

0

Downloads

0

Crossref

Received: 17 January 2026
Revised: 30 June 2026
Accepted: 11 July 2026
Published: 15 November 2026
© 2026 Editorial Board of Journal of Nanjing Medical University(Natural Sciences)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).